Sell alert! Why this expert is calling time on Temple & Webster and James Hardie shares

A leading analyst expects James Hardie and Temple & Webster shares to continue to underperform. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It may be time to hit the sell button on Temple & Webster Group Ltd (ASX: TPW) and James Hardie Industries PLC (ASX: JHX) shares.

That's according to DP Wealth Advisory's Andrew Wielandt (courtesy of The Bull).

Both S&P/ASX 200 Index (ASX: XJO) stocks have come under heavy selling pressure over the past year.

Recently trading at $4.84, online furniture and homewares retailer Temple & Webster shares are down a painful 64.8% over 12 months.

Recently trading for $26.53, building materials company James Hardie shares are down 31.1% over this same period.

For some context, the ASX 200 has gained 2% over the past full year.

And looking ahead, Wielandt doesn't expect any miraculous turnarounds for the beleaguered stocks.

Here's why.

Time to sell written on a clock.

Image source: Getty Images

Are James Hardie shares a sell?

Commenting before James Hardie's FY 2026 results release on Wednesday, which saw the ASX 200 stock close in the red, Wielandt noted:

This Australian building materials company generates most of its revenue in the United States. The acquisition of US decking business AZEK for $US8.75 billion has left the market concerned about earnings risk in response to a flat housing construction market in the US and increasing cost of living expenses.

Summarising his sell recommendation on James Hardie shares, Wielandt said, "The structure of the contentious acquisition left angry Australian investors without a vote on the deal. Too much uncertainty exists about the company's outlook."

Yesterday, James Hardie reported a 25% year-on-year increase in net sales in FY 2026 to US$4.84 billion. However, this boost was driven by the company's AZEK acquisition. Excluding AZEK's contribution, James Hardie's organic net sales fell 2% from FY 2025.

Time to sell Temple & Webster shares?

Atop recommending selling James Hardie shares, Wielandt also has a bearish outlook on Temple & Webster shares.

"TPW is an online furniture and homewares retailer," he noted.

As for Temple & Webster's decidedly dismal share price performance of late, Wielandt said:

The share price remains under significant pressure in response to weaker discretionary spending from the oil price shock and rising interest rates in Australia. The stock has also been subjected to short selling by investors betting the shares will fall.

Summarising his sell recommendation on Temple & Webster shares, Wielandt concluded:

Our recommendation is based on a weaker macroeconomic outlook. At this point, we can't see any clear and meaningful differentiation between TPW and bricks and mortar retailers or online competitors operating in the same or similar sectors.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

An oil worker in front of a pumpjack using a tablet.
Broker Notes

Why Woodside shares just got a big buy call

A leading analyst forecasts more outperformance from Woodside’s surging shares.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

Buy, hold, sell: 4DMedical, Cochlear, Westpac shares

An expert discusses his views on Westpac shares and 2 other popular ASX 200 stocks.

Read more »

Woman in business suit holds both hands out with a question mark above each hand.
Broker Notes

Buy, hold, sell: Ampol, Lendlease, BHP shares

Let's check out some new ratings on 3 ASX 200 shares today.

Read more »